Boniva
Boniva
Boniva (pronounced boh-NEE-vuh) is a brand name for the drug Ibandronate Sodium, a type of bisphosphonate used in the treatment of osteoporosis in postmenopausal women.
Pronunciation
The pronunciation of Boniva is /boʊˈniːvə/.
Etymology
The name Boniva is a brand name and does not have a known etymology. It is a trademark of Hoffmann-La Roche, a Swiss multinational healthcare company.
Usage
Boniva works by altering the cycle of bone formation and breakdown in the body. It slows bone loss while increasing bone mass, which may prevent bone fractures. Boniva is taken orally, usually once a month, or it can be administered intravenously by a healthcare provider every three months.
Related Terms
- Bisphosphonate: A class of drugs that prevent the loss of bone density.
- Osteoporosis: A medical condition in which the bones become brittle and fragile from loss of tissue.
- Ibandronate Sodium: The generic name for Boniva.
- Hoffmann-La Roche: The multinational healthcare company that owns the trademark for Boniva.
Side Effects
Like all medications, Boniva can have side effects. These can include back pain, headache, and flu-like symptoms. More serious side effects can include difficulty swallowing, severe joint or muscle pain, or jaw pain. It is important to consult with a healthcare provider for a complete list of possible side effects and interactions.
See Also
External links
- Medical encyclopedia article on Boniva
- Wikipedia's article - Boniva
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski